Loss of endogenous thymosin β4 accelerates glomerular disease
Glomerular disease is characterized by morphologic changes in podocyte cells accompanied by inflammation and fibrosis. Thymosin β4 regulates cell morphology, inflammation, and fibrosis in several organs and administration of exogenous thymosin β4 improves animal models of unilateral ureteral obstruc...
Main Authors: | Vasilopoulou, E, Kolatsi-Joannou, M, Lindenmeyer, M, White, K, Robson, M, Cohen, C, Sebire, N, Riley, P, Winyard, P, Long, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
Thymosin-β4: A key modifier of renal disease
by: Vasilopoulou, E, et al.
Published: (2018) -
The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus
by: William J. Mason, et al.
Published: (2023-04-01) -
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis
by: Joanna I. Lachowicz, et al.
Published: (2022-01-01) -
Thymosin β4 protein therapy for cardiac repair.
by: Dubé, K, et al.
Published: (2012) -
Thymosin β4 in vascular development response to research commentary.
by: Smart, N, et al.
Published: (2013)